← Evidence map

ArticleBladder cancer (Amsterdam, Netherlands)2024

Eligibility and Endpoints for Clinical Trials in Trimodality Therapy for Bladder Cancer.

Parminder Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39493817